drugset / Trial / NCT00609518

A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer

NCT00609518 ↗

Phase 2 Completed 111 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

Chemotherapy for patients with non-squamous non-small cell lung cancer. Patients are given folic acid, vitamin B12 and steroids, both before and during treatment, to reduce the side effects associated with pemetrexed. The aim is whether it is possible to simplify the folic acid and steroid schedule without increasing toxicity.

Timeline

Start
2008-02
Primary completion
2009-10
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Oral
Background Pemetrexed Small molecule 500 mg/m2 Intravenous